Press Releases

BioIVT Opens New, Larger UK Blood Donor Center on Imperial College London’s White City Campus

BioIVT’s new blood donor center is located in White City, a biotech hub, together with cell therapy, gene therapy, and pharmaceutical companies.

Thermo Fisher Scientific and UC Davis Launch Center of Excellence in Clinical Metabolomics

Thermo Fisher Scientific today announced their collaboration with the UC Davis West Coast Metabolomics Center to form The Center of Excellence in Clinical Metabolomics.

Protheragen MedAI Fully Supports In Vitro Pharmacology Research for Drug Discovery

CD Formulation Launches a Full Range of Drug Analysis Services for the Pharmaceutical Industry

Flywheel and HealthMyne Partner to Provide End-to-End Radiomic Data Management and Analysis

Flywheel and Healthmyne: Combined technology solution to accelerate radiomics research and clinical trial outcomes

Alfa Chemistry Materials Announces a New Product Offering of Quantum Dots

Rho to Coordinate Study Sponsored by NIAID to Assess Systemic Allergic Reactions to Pfizer and Moderna COVID-19 Vaccines

Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, today announced it is coordinating a study called Systemic Allergic Reactions to SARS-CoV-2 Vaccination to assess the proportion of participants with a systemic allergic reaction to the Pfizer-BioNTech and Moderna COVID-19 vaccines in populations at high risk for allergic reaction compared to a general population. This research will be important for further understanding potential risk factors for an allergic reaction to these particular vaccines, as well as to future vaccines that similarly use an mRNA nanoparticle platform. The study is sponsored and funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).

AUI and Accumen Partner to Increase Crisis Resilience to Natural and Manmade Disasters for Healthcare Sector

These new programs will ensure that healthcare organizations are better prepared to handle security threats, and power, water/waste management or supply chain disruptions.

WCG Acquires Intrinsic Imaging, Leading Full-Service Medical Imaging Core Lab

Acquisition Enriches WCG’s Scientific and Regulatory Capabilities with Comprehensive Services Ensuring Quality and Validity of Clinical Trial Results Across Drug, Medical Device and Artificial Intelligence Studies

ObvioHealth Announces Partnership with Hyfe, Integrating AI Technology for Tracking and Analyzing Coughs to Expand Data Tools for Decentralized Clinical Trials

SalivaDirect and Ubiquitome deliver cost-effective, mobile SARS-CoV-2 tests

Embargoed until June 8 at 4am Eastern Standard Time

Algorics announces acquisition of Domain Clinical Data Sciences

Algorics today announced the acquisition of Domain Clinical Data Sciences "DCDS", a clinical data services organisation based in India.

Elligo Health Research Acquires Root Health as Growth Accelerates

Elligo Health Research, today announced the acquisition of Root Health, an AI virtual assistant for clinical research. In addition, Elligo announced the addition of COO Miranda Mann Porter, Ph.D., to its leadership team.

Calyx Supports over 100 COVID-19 Vaccine Authorizations

Calyx RIM publishing module relied on for critical submissions of coronavirus vaccine trial data to global regulatory bodies.

ENPICOM to integrate renowned structural antibody prediction tools developed at the University of Oxford

ENPICOM, an innovative bioinformatics software engineering company, has announced the upcoming expansion of the IGX Platform’s capabilities towards advanced liability prediction.

Formedix and CDISC Join Forces to Provide Free Access to Ready-to-Use, CDASH-Compliant eCRFs for Accelerated Clinical Trial Set-Up

Formedix announces today a collaboration with CDISC, the global clinical research data standards development organization, to create a novel portal providing free access to ready-to-use, CDASH-compliant, annotated electronic case report forms (eCRFs) – which I thought would be of interest to you and your readers.

Sygnature Discovery expands into early CMC development

Sygnature Discovery, a leading Drug Discovery Contract Research Organisation, has announced the set-up of a state-of-the-art Early Candidate Developability Screening Group. The new service line, located at its headquarters in Nottingham, UK, will expand on the company’s offerings to customers by bridging into formal preclinical drug development and paving the way for clinical trials.

Celemics Partner with Strand Life Science and their StrandOmics Analysis Platform

Dear Nicole, Celemics, a Korea-based biomaterial technology leader that has developed a range of innovative biomaterials and sequencing methods used in the medical, pharmaceutical, microbiome, synthetic biology, and breeding fields, has announced a partnership with Strand Life Sciences, a leading precision medicine informatics company.

Veranex Announces Investment From Summit Partners to Form Comprehensive Concept-to-Commercialization Medtech Services Company

Veranex today announced the formation of the first concept-to-commercialization global service provider dedicated to the medtech industry. As the first phase in building this global entity, Veranex has acquired three complementary solution providers: Ximedica, Quartesian, and Boston Healthcare Associates.

Perlara partners with Vivan Therapeutics to tackle rare genetic diseases

Today, Perlara PBC, a rare disease public benefit company, has announced a collaboration with Vivan Therapeutics, developers of personalised therapeutics, to identify novel therapeutics for rare genetic diseases.